January 28, 2019
This morning medical device company Masimo announced FDA clearance for the measurement of respiration rate from a photoplethysmogram (RRp), so that it may now be used on the MightSat Rx finger pulse oximeter. The latest clearance also means the technology can be used at home by patients.
The new technology will be able to calculate a user’s respiration rate, which is the count of breaths per...
January 22, 2019
Laid to rest. A longstanding legal dispute between Apple and Valencell over infringement on four patents and deceptive trade practices was quietly put to bed last year. The two companies submitted their dismissal to the US District Court North Carolina in September, with no other details on how the settlement shook out.
When this case (and a similar one against Fitbit) was first filed in early...
December 3, 2018
The FDA has announced the winners of the opioid addiction innovation challenge the agency launched last May. Out of more than 250 applications from medical device developers, the FDA selected eight winners.
"While these products will not automatically receive marketing authorization from the FDA, the device developers will receive increased interaction with CDRH experts, guidance for clinical...
September 10, 2018
Furthering its move into the neonatal space, this morning non-invasive patient monitoring device and sensor maker Masimo announced that it landed FDA clearance for its acoustic respiration sensor, the RAS-45, to be used with infants and neonatal patients as part of its Rainbow Acoustic Monitoring (RAM) system.
Previously, the company's RAS-45 and RAS-125 sensors were cleared for adults and...
July 9, 2018
Prying eyes. Polar now joins Strava in the list of fitness app makers accidentally betraying military information. According to a report from the Dutch publication De Correspondent, an opt-in feature within the app posts users’ routes to an online map can become a gateway to their private information with diligent searching and a simple modification of the browser’s web address. Working with the...
June 21, 2018
Earlier this week medical device maker Masimo and Thermomedics, a Positive ID company, launched their new contactless, Bluetooth-enabled thermometer in the US market. The thermometer, called TIR-1, will be able to integrate with the Masimo Root patient monitoring and connectivity platform.
"TIR-1 is a great example of the powerful expandability and versatility of the Root platform, and of our...
May 31, 2017
Cure Forward shuts down. Cure Forward, a clinical trial matching platform aimed at cancer patients, has shut down its operations. The Cambridge, Massachusetts startup launched in 2015 with $15 million in venture backing, but was unable to generate new revenue going forward. In a message on its website, Cure Forward referred visitors to its site to the Cancer Support Community in their quest to...
April 10, 2017
Irvine, California-based Masimo, makers of a suite of non-invasive patient monitoring devices and sensors, has expanded the capabilities of its connected platform to allow physicians to view more data, more clearly and in the configuration that works best for them.
Clinicians get a lot of data from Masimo’s bedside monitoring devices – which include the recently FDA-cleared forehead sensor,...
February 1, 2017
Apple sees health as the future, the Apple Watch as the present. On Apple's Q1 conference call, CEO Tim Cook almost didn't mention the company's healthcare operations or aspirations at all. But in response to the final investor question, when asked whether future updates to the iPhone would be incremental, Cook alluded to health as one of the areas where the company sees substantive...
June 9, 2016
Jawbone quietly acquired a company last year that could shed some light on the company's rumored clinical wearable, MobiHealthNews has learned. Spectros, a startup founded by current Jawbone Chief Medical Officer David Benaron, was acquired by Jawbone in 2015. The company confirmed the news to MobiHealthNews in an email. Benaron is a serial entrepreneur whose previous company, Insite, was...